Jiaying pharmaceutical has released a large amount of "skid" hot money

[chinapharma.com news] Jiaying pharmaceutical finally opened the trading limit yesterday after planning to restructure and resume trading for three consecutive days By the end of the day, the stock was 7.15 yuan, down 5.92%, with trading volume reaching 146 million shares After hours data shows that the first-line hot money Huatai Securities Shenzhen Yitian road Rongchao business center appears to buy a seat Three "one" word trading limit was reinstated yesterday Jiaying pharmaceutical opened its trading limit at 9:56 and separated from the board at 9:30 After the continuous low volatility, it rose in a straight line at 13:30, once turning red, with an increase of more than 5% As of the closing, Jiaying pharmaceutical reported 7.15 yuan, down 5.92%, with a turnover rate of 31.41% The volume of trading reached 146 million shares, a high volume since the stock was listed On May 22, Jiaying pharmaceutical decided to resume trading and continue to promote restructuring, but did not disclose the restructuring plan within the expected time As a result, Jiaying Pharmaceutical Co., Ltd has been trading down for three consecutive days since its resumption on May 22 In fact, since the middle of 2017, Jiaying pharmaceutical fell all the way Statistics show that since June 1, 2017, the stock price of Jiaying pharmaceutical has been cut back in 242 trading days, with a cumulative decline of 48.25% Basically speaking, Jiaying pharmaceutical disclosed its 2017 annual report during the suspension period, showing its first loss in 10 years of listing According to the annual report, the company achieved a net profit of - 215 million yuan last year, which is still different from the previously published 2017 performance express data by - 150 million yuan The first-line hot money appeared to buy 31.09 million yuan after combing the data found that the top five seats of yesterday's trading were hot money, and a "Death Squadron" entered yesterday The top five seats bought a total of RMB 149 million yesterday, i.e CSCI Fuling square road, Chongqing, bought RMB 54.2128 million yesterday, and Huatai Securities Rongchao business center, Yitian Road, Shenzhen, bought RMB 31.089 million yesterday It should be pointed out that, in addition to Jiaying pharmaceutical, Huatai Securities Shenzhen Yitian road Rongchao business center appeared in a number of stocks yesterday, including yuebo power, three-dimensional silk, Haolilai and Tianshen entertainment Huatai Securities Shenzhen Yitian road Rongchao business center has participated in several stocks, such as weixinkang, Changshan pharmaceutical, Kerui international, and jianruihuaneng In terms of sales, the top five seats sold a total of 646 million yuan yesterday, of which Chongqing Branch of Hua'an securities sold 276 million yuan, ranking first; Qianjiang Road, Hangzhou, Great Wall securities sold 133 million yuan, ranking second; didanghu Road, Shaoxing, Tibet Oriental Wealth securities sold 107 million yuan, ranking third "Jiaying pharmaceutical itself is a stock maker After the avalanche continued to fall and stop, someone pried on the board to bet against the rebound In addition, the makers are competing, buying and selling by themselves to attract the market's attention This kind of stock risk is still large, so investors don't have to lick the blood " An analyst, who declined to be named, said in an interview with the Volkswagen securities news yesterday Jiaying pharmaceutical announced last night that the company is currently promoting the restructuring of non-public issuance of shares and payment of cash to purchase the equity of Guiyang Dechang Xiang Pharmaceutical Co., Ltd until now, the company's due diligence and demonstration evaluation of the underlying assets have not been completed, and the company has not been able to determine the restructuring plan, which has significant uncertainty At the time of suspension of trading, the company indicated that it planned to purchase 99.7% equity of Dechang Xiang through non-public issuance of shares and cash payment Original title: Jiaying pharmaceutical's "prying board" first-line hot money appeared reporter: he Yuxiao